drugset / Trial / NCT00005821

Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer

NCT00005821 ↗

Treatment

Summary

RATIONALE: Diagnostic procedures such as sentinel lymph node biopsy may improve the ability to detect breast cancer and determine the extent of disease. PURPOSE: Phase II trial to study the effectiveness of sentinel lymph node biopsy to assess axillary lymph nodes in women who have stage I or stage II breast cancer.

Timeline

Start
1998-12
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background patent blue V dye Diagnostic / imaging agent — Other